| Literature DB >> 33556543 |
Tianfang Ma1, Shanshan Bai1, Yanfeng Qi1, Yang Zhan1, Nathan Ungerleider2, Derek Y Zhang3, Taavi Neklesa4, Eva Corey5, Scott M Dehm6, Kun Zhang7, Erik K Flemington8, Yan Dong9.
Abstract
Upregulation of androgen receptor splice variants (AR-Vs), especially AR-V7, is associated with castration resistance of prostate cancer. At the RNA level, AR-V7 upregulation is generally coupled with increased full-length AR (AR-FL); consequently, AR-V7 and AR-Vs collectively constitute a minority of the AR population. However, Western blotting showed that the relative abundance of AR-V proteins is much higher in many castration-resistant prostate cancers (CRPCs). To address the mechanism underlying this discrepancy, we analyzed RNA-seq data from ~350 CRPC samples and found a positive correlation between all canonical and alternative AR splicing. This indicates that increased alternative splicing is not at the expense of canonical splicing. Instead, androgen deprivation releases AR-FL from repressing the transcription of the AR gene to induce coordinated increase of AR-FL and AR-V mRNAs. At the protein level, however, androgen deprivation induces AR-FL, but not AR-V, degradation. Moreover, AR-V7 is translated much faster than AR-FL. Thus, androgen-deprivation-induced AR-gene transcription and AR-FL protein decay, together with efficient AR-V7 translation, explain the discrepancy between the relative AR-V mRNA and protein abundances in many CRPCs, highlighting the inevitability of AR-V induction after endocrine therapy.Entities:
Keywords: AR negative autoregulation; AR-V mRNA stability; AR-V protein stability; AR-V translation; Castration resistance; Castration-resistant prostate cancer
Mesh:
Substances:
Year: 2021 PMID: 33556543 PMCID: PMC7940584 DOI: 10.1016/j.canlet.2020.12.037
Source DB: PubMed Journal: Cancer Lett ISSN: 0304-3835 Impact factor: 8.679